No New Safety Signals With Ruxolitinib Cream Used in Combination With Systemic Therapies for Atopic Dermatitis: A Multicenter Retrospective Study. // Journal of the American Academy of Dermatology. – URL: https://www.sciencedirect.com/science/article/pii/S0190962226039174?dgcid=rss_sd_all
No New Safety Signals With Ruxolitinib Cream Used in Combination With Systemic Therapies for Atopic Dermatitis: A Multicenter Retrospective Study. Journal of the American Academy of Dermatology. https://www.sciencedirect.com/science/article/pii/S0190962226039174?dgcid=rss_sd_all
“No New Safety Signals With Ruxolitinib Cream Used in Combination With Systemic Therapies for Atopic Dermatitis: A Multicenter Retrospective Study.” Journal of the American Academy of Dermatology.
@article{article55707,
title = {No New Safety Signals With Ruxolitinib Cream Used in Combination With Systemic Therapies for Atopic Dermatitis: A Multicenter Retrospective Study},
journal = {Journal of the American Academy of Dermatology},
url = {https://www.sciencedirect.com/science/article/pii/S0190962226039174?dgcid=rss_sd_all}
}